Citation Impact
Citing Papers
MicroRNA Gene Expression Deregulation in Human Breast Cancer
2005 Standout
Decision Curve Analysis: A Novel Method for Evaluating Prediction Models
2006 Standout
Allelotype analysis of mouse lung carcinomas reveals frequent allelic losses on chromosome 4 and an association between allelic imbalances on chromosome 6 and K-ras activation.
1994
Guidelines for the welfare and use of animals in cancer research
2010 Standout
Breast cancer
2019 Standout
CDK inhibitors: positive and negative regulators of G1-phase progression
1999 Standout
Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer
2001 Standout
The history of cancer epigenetics
2004 Standout
Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in Carcinogenesis
2000 Standout
Papillomavirus infections — a major cause of human cancers
1996 StandoutNobel
The von Hippel–Lindau Tumor Suppressor Gene
2001 StandoutNobel
Population-based family studies in genetic epidemiology
2005
Molecular basis of the VHL hereditary cancer syndrome
2002 StandoutNobel
Short telomeres on human chromosome 17p
1998
ATM and related protein kinases: safeguarding genome integrity
2003 Standout
Cancer Risk Prediction Models: A Workshop on Development, Evaluation, and Application
2005
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
The mini-driver model of polygenic cancer evolution
2015 StandoutNobel
Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations
2007
Fluorescence-activated cell sorting of transfected cells
1997 StandoutNobel
von Hippel-Lindau Disease
1997 StandoutNobel
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
2007 Standout
Mouse Modifier Genes in Mammary Tumorigenesis and Metastasis
2008
LIT1, an imprinted antisense RNA in the human KvLQT1 locus identified by screening for differentially expressed transcripts using monochromosomal hybrids
1999
A DNA damage checkpoint response in telomere-initiated senescence
2003 StandoutNature
High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays
1998 Standout
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
2006 Standout
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
The pVHL-associated SCF ubiquitin ligase complex: Molecular genetic analysis of elongin B and C, Rbx1 and HIF-1α in renal cell carcinoma
2001 StandoutNobel
Mitochondrial control of cell death
2000 Standout
Papillomaviruses and cancer: from basic studies to clinical application
2002 StandoutNobel
The DNA Damage Response: Making It Safe to Play with Knives
2010 Standout
HIF hydroxylation and the mammalian oxygen-sensing pathway
2003 StandoutNobel
The BOADICEA model of genetic susceptibility to breast and ovarian cancer
2004
Male breast cancer
2006 Standout
Breast Cancer Risk Among Male BRCA1 and BRCA2 Mutation Carriers
2007
Potent Prostaglandin A1 Analogs That Suppress Tumor Cell Growth through Induction of p21 and Reduction of Cyclin E
1998 StandoutNobel
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
A tiger behind many doors: multiple genetic pathways to malignant glioma
1995
An imprinted gene p57KIP2 is mutated in Beckwith–Wiedemann syndrome
1996
Chromosomal Imbalances in Papillary Renal Cell Carcinoma
1998
Breast-Cancer Stromal Cells with TP53 Mutations and Nodal Metastases
2007
Pilot Evaluation of 1p and 19q Deletions in Anaplastic Oligodendrogliomas Collected by a National Cooperative Cancer Treatment Group
2001
The Shortest Telomere, Not Average Telomere Length, Is Critical for Cell Viability and Chromosome Stability
2001 StandoutNobel
Cell cycle, CDKs and cancer: a changing paradigm
2009 Standout
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours
2016 Standout
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
2003 Standout
Inhibitors of mammalian G1 cyclin-dependent kinases.
1995 Standout
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
2012 Standout
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 Standout
Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers
1997 Standout
Treatment of Breast Cancer
1998
A CHEK2 Genetic Variant Contributing to a Substantial Fraction of Familial Breast Cancer
2002
Molecular genetic analysis of the von Hippel-Lindau disease (VHl) tumour suppressor gene in gonadal tumours
1995
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
1995 Standout
The genetics and genomics of cancer
2003
Population BRCA1 and BRCA2 Mutation Frequencies and Cancer Penetrances: A Kin–Cohort Study in Ontario, Canada
2006
The VHL tumour-suppressor gene paradigm
1998 StandoutNobel
Brain Tumors
2001 Standout
Inactivation of the von Hippel–Lindau ( VHL ) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: Evidence for a VHL ‐independent pathway in clear cell renal tumourigenesis
1998
Identifying breast cancer susceptibility genes – a review of the genetic background in familial breast cancer
2019
The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p.
2001
How To Build and Interpret a Nomogram for Cancer Prognosis
2008 Standout
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
Long-term genome stability and minimal genotypic and phenotypic alterations in HPV16 E7-, but not E6-, immortalized human uroepithelial cells.
1994
Alterations of Chromosome Arms 1p and 19q as Predictors of Survival in Oligodendrogliomas, Astrocytomas, and Mixed Oligoastrocytomas
2000
HIF hydroxylation and the mammalian oxygen-sensing pathway
2003 StandoutNobel
CHEK2*1100delC and Susceptibility to Breast Cancer: A Collaborative Analysis Involving 10,860 Breast Cancer Cases and 9,065 Controls from 10 Studies
2004
Cancer Cell Cycles
1996 StandoutScience
Short telomeres on human chromosome 17p
1998
Ovarian cancer statistics, 2018
2018 Standout
Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status.
1996
Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: identification of a new region at 11q23.3.
1995
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
Characterization ofBRCA1andBRCA2Mutations in a Large United States Sample
2006
Developmental regulation of a cyclin-dependent kinase inhibitor controls postembryonic cell cycle progression in Caenorhabditis elegans
1998 StandoutNobel
p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene.
1995
Multidisciplinary Meeting on Male Breast Cancer: Summary and Research Recommendations
2010 Standout
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Recommendation Statement.
2015
Integrating Genetic Approaches into the Discovery of Anticancer Drugs
1997 StandoutScienceNobel
Role ofVHLGene Mutation in Human Cancer
2004 StandoutNobel
Prophylactic Thyroidectomy in 75 Children and Adolescents with Hereditary Medullary Thyroid Carcinoma: German and Austrian Experience
1998
Works of B. Ponder being referenced
IMMUNOHISTOCHEMICAL STUDY OF CALCITONIN GENE‐RELATED PEPTIDE IN HUMAN MEDULLARY CARCINOMA AND C CELL HYPERPLASIA
1987
A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes
2002
Familial cancer syndromes
1994
Report of the committee on chromosome and gene loss in human neoplasia
1991